SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medico Remedies - Quaterly Results

12 Feb 2024 Evaluate
The sales is pegged at Rs. 297.72 millions for the December 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 388.46 millions during the year-ago period.Net Profit of the company move down -35.75% to Rs. 14.45  millions from Rs. 22.49 millions  in the same quarter last year.Operating profit for the quarter ended December 2023 decreased to 30.05 millions as compared to 42.52 millions of corresponding quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 297.72 388.46 -23.36 1035.98 1124.46 -7.87 1404.37 1210.21 16.04
Other Income 2.73 8.64 -68.40 15.44 40.10 -61.50 39.47 20.29 94.53
PBIDT 30.05 42.52 -29.33 98.09 103.61 -5.33 135.67 93.63 44.90
Interest 2.22 2.00 11.00 5.76 5.41 6.47 7.47 6.62 12.84
PBDT 27.83 40.52 -31.32 92.33 98.20 -5.98 128.20 87.01 47.34
Depreciation 7.20 7.37 -2.31 21.42 19.94 7.42 27.20 22.18 22.63
PBT 20.63 33.15 -37.77 70.91 78.26 -9.39 101.00 64.83 55.79
TAX 6.18 10.66 -42.03 18.99 23.51 -19.23 28.57 16.71 70.98
Deferred Tax -0.50 0.06 -933.33 -0.76 2.93 -125.94 3.62 -1.24 -391.94
PAT 14.45 22.49 -35.75 51.92 54.75 -5.17 72.43 48.12 50.52
Equity 165.97 165.97 0.00 165.97 165.97 0.00 165.97 165.97 0.00
PBIDTM(%) 10.09 10.95 -7.79 9.47 9.21 2.76 9.66 7.74 24.87

Medico Remedies Share Price

41.24 1.77 (4.48%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×